Dr Anna Nowak

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone +61 8 9346 3841
Fax +61 8 9346 3390

Map

Selected grants

2012

  • Phase III trial of Concurrent & Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma; Nowak A, Rosenthal M, Simes R, Ryan G, Drummond K; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2004

  • The Zest Trial : a double-blind, placebo-controlled trial of Zolofts effects on symptoms and survival time in advanced cancer; Stockler M, Byrne M, Nowak A, Wilken N, Turner J, Wyld D; Anti Cancer Foundation of South Australia/Research Support.
  • The Zest Trial : a double-blind, placebo-controlled trial of Zolofts effects on symptoms and survival time in advanced cancer; Stockler M, Byrne M, Nowak A, Wilken N, Turner J, Wyld D; Cancer Council New South Wales/Research Project Grants.

2003

  • Validating the Pt DATA form as a pragmatic measure of health-related quality of life for oncology practice and research; Nowak A; Medical Oncology Group of Australia Inc/Research Grant.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Nowak, A., Cebon, J., Hargreaves, C., Dhillon, H., Findlay, M., Gebski, V., Stockler, M. (2008). Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology, 4, 55-67.
  • Ferguson, T., Wilcken, N., Vagg, R., Ghersi, D., Nowak, A. (2007). Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews, Art. No.: CD004421(4), 1-50. [More Information]
  • Cebon, J., Hargreaves, C., Stockler, M., Boyer, M., Nowak, A., Dhillon, H., Gebski, V., Dickman, B., Findlay, M., Poon, A., et al (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95(7), 853-861. [More Information]
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.
  • Nowak, A., Stockler, M., Chow, P., Findlay, M. (2005). Use of Tamoxifen in Advanced-Stage Hepatocellular Carcinoma. Cancer, 103(7), 1408-1414. [More Information]
  • Nowak, A., Stockler, M., Byrne, M. (2004). Assessing Quality Of Life During Chemotherapy For Pleural Mesothelioma: Feasibility, Validity, And Results Of Using The European Organization For Research And Treatment Of Cancer Core Quality Of Life Questionnaire And Lung Cancer Module. Journal of Clinical Oncology, 22(15), 3172-3180.
  • Nowak, A., Wilcken, N., Stockler, M., Hamilton, A., Ghersi, D. (2004). Systematic Review Of Taxane-Containing Versus Non-Taxane-Containing Regimens For Adjuvant And Neoadjuvant Treatment Of Early Breast Cancer. Lancet Oncology, 5(6), 372-380.
  • Nowak, A., Chow, P., Findlay, M. (2004). Systemic Therapy For Advanced Hepatocellular Carcinoma: A Review. European Journal of Cancer, 40(10), 1474-1484. [More Information]

2008

  • Nowak, A., Cebon, J., Hargreaves, C., Dhillon, H., Findlay, M., Gebski, V., Stockler, M. (2008). Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology, 4, 55-67.

2007

  • Ferguson, T., Wilcken, N., Vagg, R., Ghersi, D., Nowak, A. (2007). Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews, Art. No.: CD004421(4), 1-50. [More Information]

2006

  • Cebon, J., Hargreaves, C., Stockler, M., Boyer, M., Nowak, A., Dhillon, H., Gebski, V., Dickman, B., Findlay, M., Poon, A., et al (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95(7), 853-861. [More Information]
  • Stockler, M., Heritier, S., Nowak, A., Goldstein, D., Turner, J., Jefford, M., Glasgow, A., Abdi, E., Beale, P., Carter, C. (2006). The time taken to complete quality of life questionnaires in an advanced cancer trial. Journal of Clinical Oncology, 24(18S), 491s-491s.

2005

  • Nowak, A., Stockler, M., Chow, P., Findlay, M. (2005). Use of Tamoxifen in Advanced-Stage Hepatocellular Carcinoma. Cancer, 103(7), 1408-1414. [More Information]

2004

  • Nowak, A., Stockler, M., Byrne, M. (2004). Assessing Quality Of Life During Chemotherapy For Pleural Mesothelioma: Feasibility, Validity, And Results Of Using The European Organization For Research And Treatment Of Cancer Core Quality Of Life Questionnaire And Lung Cancer Module. Journal of Clinical Oncology, 22(15), 3172-3180.
  • Nowak, A., Wilcken, N., Stockler, M., Hamilton, A., Ghersi, D. (2004). Systematic Review Of Taxane-Containing Versus Non-Taxane-Containing Regimens For Adjuvant And Neoadjuvant Treatment Of Early Breast Cancer. Lancet Oncology, 5(6), 372-380.
  • Nowak, A., Chow, P., Findlay, M. (2004). Systemic Therapy For Advanced Hepatocellular Carcinoma: A Review. European Journal of Cancer, 40(10), 1474-1484. [More Information]

To update your profile click here. For support on your academic profile contact .